These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6258761)

  • 41. 1,25-Dihydroxyvitamin D production after stimulation with synthetic human parathyroid hormone (1-34) in hypoparathyroid and renal tubular disorders.
    Yasuda T; Nakajima H
    Endocrinol Jpn; 1984 Aug; 31(4):407-15. PubMed ID: 6097438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of parathyroid hormone and calcitonin on plasma and nephrogenous cyclic adenosine-3',5'-monophosphate in normal subjects and in pathological conditions.
    Caniggia A; Gennari C; Lore F; Nuti R; Galli M
    Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):99-105. PubMed ID: 6257524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypo-hyperparathyroidism: evidence for a defective parathyroid hormone.
    Connors MH; Irias JJ; Golabi M
    Pediatrics; 1977 Sep; 60(3):343-8. PubMed ID: 197477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency.
    Rude RK; Oldham SB; Singer FR
    Clin Endocrinol (Oxf); 1976 May; 5(3):209-24. PubMed ID: 182417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impaired responsiveness to the effect of glucagon on plasma adenosine 3':5'-cyclic monophosphate in normal man.
    Hendy GN; Tomlinson S; O'Riordan JL
    Eur J Clin Invest; 1977 Jun; 7(3):155-60. PubMed ID: 196859
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Value of a simplified test using biosynthetic 1,34 parathormone in the exploration of pseudo-hypoparathyroidism].
    Hassler P; Bolender C; Vuillemin MO; Reville P
    Presse Med; 1993 Sep; 22(28):1322. PubMed ID: 8248059
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effects of synthetic human parathyroid hormone (1-34) on plasma and urinary adenosine 3',5'-monophosphate and urinary phosphate and calcium in patients with hypoparathyroidism and pseudohypoparathyroidism (author's transl)].
    Konagaya Y; Takatsuki K; Tomita A
    Nihon Naibunpi Gakkai Zasshi; 1981 Nov; 57(11):1591-608. PubMed ID: 6276237
    [No Abstract]   [Full Text] [Related]  

  • 48. Reversible resistance to the renal action of parathyroid hormone in man.
    Tomlinson S; Hendy GN; Pemberton DM; O'Riordan JL
    Clin Sci Mol Med; 1976 Jul; 51(1):59-69. PubMed ID: 181194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic disorders involving parathyroid hormone and calcitonin.
    Aurbach GD
    Birth Defects Orig Artic Ser; 1971 May; 7(6):48-54. PubMed ID: 4155962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parathyroid hormone (PTH)-mediated rise in urinary cyclic AMP(UcAMP) during acute extracellular fluid (ECF) expansion natriuresis in man.
    Shaw JW; Oldham SB; Bethune JE; Fichman MP
    J Clin Endocrinol Metab; 1974 Aug; 39(2):311-5. PubMed ID: 4371642
    [No Abstract]   [Full Text] [Related]  

  • 51. [The diagnostic value of the determination of cyclic 3',5'-adenosine monophosphate (cAMP) in urine].
    Gennari C; Galli M; Montagnani M; D'Amore I
    Quad Sclavo Diagn; 1976 Mar; 12(1):15-38. PubMed ID: 190633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal response to intravenous phosphate load in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
    Aperia A; Broberger O; Bergstrand CG; Zetterström R
    Acta Paediatr Scand; 1967 Jul; 56(4):357-64. PubMed ID: 6039048
    [No Abstract]   [Full Text] [Related]  

  • 53. Plasma cyclic-AMP response to parathyroid hormone in Turner's syndrome and Albright's hereditary osteodystrophy.
    Ashby JP; Renton WB; MacPherson JN; Price WH; Abbott SR
    Clin Endocrinol (Oxf); 1979 Jun; 10(6):553-6. PubMed ID: 225067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of exogenous parathyroid hormone on plasma and urinary adenosine 3', 5'-cyclic monophosphate in man.
    Tomlinson S; Barling PM; Albano JD; Brown BL; O'Riordan JL
    Clin Sci Mol Med; 1974 Nov; 47(5):481-92. PubMed ID: 4373203
    [No Abstract]   [Full Text] [Related]  

  • 55. A 6-hour human parathyroid hormone (1-34) infusion protocol: studies in normal and hypoparathyroid subjects.
    McElduff A; Lissner D; Wilkinson M; Cornish C; Posen S
    Calcif Tissue Int; 1987 Nov; 41(5):267-73. PubMed ID: 2825934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patterns of cyclic 3'5'-adenosine monophosphate excretion in parathyroid dysfunction.
    Ullrich IH; Lizarralde G
    Chronobiologia; 1977; 4(3):199-204. PubMed ID: 202439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blunted plasma cyclic adenosine monophosphate response to isoproterenol in pseudohypoparathyroidism.
    Carlson HE; Brickman AS
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1323-6. PubMed ID: 6302127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of parathyroid gland function using sodium bicarbonate infusion test for 22q11.2 deletion syndrome.
    Nagasaki K; Iwasaki Y; Ogawa Y; Kikuchi T; Uchiyama M
    Horm Res Paediatr; 2011; 75(1):14-8. PubMed ID: 20664180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man.
    Kaminsky NI; Broadus AE; Hardman JG; Jones DJ; Ball JH; Sutherland EW; Liddle GW
    J Clin Invest; 1970 Dec; 49(12):2387-95. PubMed ID: 5480862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcium potentiates the cyclic nucleotide and phosphaturic response to parathyroid hormone infusion.
    Bikle DD; Herman RH
    J Clin Endocrinol Metab; 1983 Jan; 56(1):11-7. PubMed ID: 6292254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.